Carsten Schultz‐Fademrecht

2.4k total citations
38 papers, 1.2k citations indexed

About

Carsten Schultz‐Fademrecht is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, Carsten Schultz‐Fademrecht has authored 38 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 18 papers in Oncology and 13 papers in Organic Chemistry. Recurrent topics in Carsten Schultz‐Fademrecht's work include Peptidase Inhibition and Analysis (6 papers), Protein Degradation and Inhibitors (5 papers) and Protein Kinase Regulation and GTPase Signaling (5 papers). Carsten Schultz‐Fademrecht is often cited by papers focused on Peptidase Inhibition and Analysis (6 papers), Protein Degradation and Inhibitors (5 papers) and Protein Kinase Regulation and GTPase Signaling (5 papers). Carsten Schultz‐Fademrecht collaborates with scholars based in Germany, Italy and United Kingdom. Carsten Schultz‐Fademrecht's co-authors include Philip Jones, Michael Rowley, Herbert Waldmann, Alfred Wittinghofer, Jesus M. Ontoria, Sandip Murarka, Federica Ferrigno, Rita Scarpelli, Matthias Baumann and Eyad K. Fansa and has published in prestigious journals such as Angewandte Chemie International Edition, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Carsten Schultz‐Fademrecht

37 papers receiving 1.2k citations

Peers

Carsten Schultz‐Fademrecht
Keith Menear United Kingdom
Xiaoling Cockcroft United Kingdom
Lan-Zhen Wang United Kingdom
Gui‐Dong Zhu United States
Keith R. Hornberger United States
Frankie Lam Australia
Elena Casale Italy
Rachel E. Davis United States
Yanke Liang United States
Keith Menear United Kingdom
Carsten Schultz‐Fademrecht
Citations per year, relative to Carsten Schultz‐Fademrecht Carsten Schultz‐Fademrecht (= 1×) peers Keith Menear

Countries citing papers authored by Carsten Schultz‐Fademrecht

Since Specialization
Citations

This map shows the geographic impact of Carsten Schultz‐Fademrecht's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carsten Schultz‐Fademrecht with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carsten Schultz‐Fademrecht more than expected).

Fields of papers citing papers by Carsten Schultz‐Fademrecht

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carsten Schultz‐Fademrecht. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carsten Schultz‐Fademrecht. The network helps show where Carsten Schultz‐Fademrecht may publish in the future.

Co-authorship network of co-authors of Carsten Schultz‐Fademrecht

This figure shows the co-authorship network connecting the top 25 collaborators of Carsten Schultz‐Fademrecht. A scholar is included among the top collaborators of Carsten Schultz‐Fademrecht based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carsten Schultz‐Fademrecht. Carsten Schultz‐Fademrecht is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Depta, Laura, Niklas Uhlenbrock, Jörn Weisner, et al.. (2021). Cellular model system to dissect the isoform-selectivity of Akt inhibitors. Nature Communications. 12(1). 5297–5297. 32 indexed citations
2.
Martín‐Gago, Pablo, Eyad K. Fansa, Sandip Murarka, et al.. (2017). Covalent Protein Labeling at Glutamic Acids. Cell chemical biology. 24(5). 589–597.e5. 70 indexed citations
3.
Martín‐Gago, Pablo, Eyad K. Fansa, Sandip Murarka, et al.. (2017). A PDE6δ‐KRas Inhibitor Chemotype with up to Seven H‐Bonds and Picomolar Affinity that Prevents Efficient Inhibitor Release by Arl2. Angewandte Chemie International Edition. 56(9). 2423–2428. 71 indexed citations
4.
Kremer, Lea, Carsten Schultz‐Fademrecht, Matthias Baumann, et al.. (2017). Discovery of a Novel Inhibitor of the Hedgehog Signaling Pathway through Cell‐based Compound Discovery and Target Prediction. Angewandte Chemie. 129(42). 13201–13205. 7 indexed citations
5.
Kremer, Lea, Carsten Schultz‐Fademrecht, Matthias Baumann, et al.. (2017). Discovery of a Novel Inhibitor of the Hedgehog Signaling Pathway through Cell‐based Compound Discovery and Target Prediction. Angewandte Chemie International Edition. 56(42). 13021–13025. 20 indexed citations
6.
Papke, Bjoern, Sandip Murarka, Pablo Martín‐Gago, et al.. (2016). Identification of pyrazolopyridazinones as PDEδ inhibitors. Nature Communications. 7(1). 11360–11360. 131 indexed citations
7.
Chakedis, Jeffery, Randall P. French, Michele Babicky, et al.. (2016). Characterization of RON protein isoforms in pancreatic cancer: implications for biology and therapeutics. Oncotarget. 7(29). 45959–45975. 24 indexed citations
8.
Engel, Julian, Christian Becker, Jonas Lategahn, et al.. (2016). Inhibition wirkstoffresistenter Mutationsvarianten der Rezeptortyrosinkinase EGFR. Angewandte Chemie. 128(36). 11069–11073. 5 indexed citations
9.
Barf, Tjeerd, Allard Kaptein, Dennis Demont, et al.. (2011). Structure-based lead identification of ATP-competitive MK2 inhibitors. Bioorganic & Medicinal Chemistry Letters. 21(12). 3818–3822. 19 indexed citations
10.
Oubrie, Arthur, Allard Kaptein, Edwin de Zwart, et al.. (2011). Novel ATP competitive MK2 inhibitors with potent biochemical and cell-based activity throughout the series. Bioorganic & Medicinal Chemistry Letters. 22(1). 613–618. 13 indexed citations
11.
Kaptein, Allard, Arthur Oubrie, Edwin de Zwart, et al.. (2011). Discovery of selective and orally available spiro-3-piperidyl ATP-competitive MK2 inhibitors. Bioorganic & Medicinal Chemistry Letters. 21(12). 3823–3827. 17 indexed citations
12.
Ferrigno, Federica, Danila Branca, Olaf Kinzel, et al.. (2009). Development of substituted 6-[4-fluoro-3-(piperazin-1-ylcarbonyl)benzyl]-4,5-dimethylpyridazin-3(2H)-ones as potent poly(ADP–ribose) polymerase-1 (PARP-1) inhibitors active in BRCA deficient cells. Bioorganic & Medicinal Chemistry Letters. 20(3). 1100–1105. 14 indexed citations
13.
Ontoria, Jesus M., Jonathan C. Cruz, Michael Rowley, et al.. (2009). Histone deacetylase inhibitors with a primary amide zinc binding group display antitumor activity in xenograft model. Bioorganic & Medicinal Chemistry Letters. 19(11). 3081–3084. 26 indexed citations
14.
Bisbocci, Monica, Raffaele Ingenito, Jesus M. Ontoria, et al.. (2009). Discovery and SAR of novel, potent and selective hexahydrobenzonaphthyridinone inhibitors of poly(ADP-ribose)polymerase-1 (PARP-1). Bioorganic & Medicinal Chemistry Letters. 20(2). 448–452. 12 indexed citations
15.
Scarpelli, Rita, Mauro Cerretani, Federica Ferrigno, et al.. (2009). Synthesis and biological evaluation of substituted 2-phenyl-2H-indazole-7-carboxamides as potent poly(ADP-ribose) polymerase (PARP) inhibitors. Bioorganic & Medicinal Chemistry Letters. 20(2). 488–492. 20 indexed citations
16.
17.
Pescatore, Giovanna, Olaf Kinzel, Massimiliano Fonsi, et al.. (2008). Optimization of a series of potent and selective ketone histone deacetylase inhibitors. Bioorganic & Medicinal Chemistry Letters. 18(20). 5528–5532. 11 indexed citations
18.
Jones, Philip, Matthew J. Bottomley, Andrea Carfı́, et al.. (2008). 2-Trifluoroacetylthiophenes, a novel series of potent and selective class II histone deacetylase inhibitors. Bioorganic & Medicinal Chemistry Letters. 18(11). 3456–3461. 52 indexed citations
19.
Schultz‐Fademrecht, Carsten, Prashant Deshmukh, Karine Malagu, Panayiotis A. Procopiou, & Anthony G. M. Barrett. (2004). Directed ring-closing metathesis of trienes by silyl substitution. Tetrahedron. 60(35). 7515–7524. 8 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Keith Menear Breakdown of academic impact, for papers by Xiaoling Cockcroft Breakdown of academic impact, for papers by Lan-Zhen Wang Breakdown of academic impact, for papers by Gui‐Dong Zhu Breakdown of academic impact, for papers by Keith R. Hornberger Breakdown of academic impact, for papers by Frankie Lam Breakdown of academic impact, for papers by Elena Casale Breakdown of academic impact, for papers by Rachel E. Davis Breakdown of academic impact, for papers by Yanke Liang
Rankless by CCL
2026